Forte Biosciences (FBRX) Misses Q1 EPS by 137c

Forte Biosciences (NASDAQ: FBRX) reported Q1 EPS of ($1.37).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
• BTIG’s Krinsky warns 2000-like signals are mounting
• Coherus Oncology hires Oppenheimer to sell biosimilar assets